Meet Researchers, Doctors, Patients
This is your chance to learn all about the hearing regeneration treatment FX-322 being developed by Frequency Therapeutics. We spoke with Carl LeBel about the promising results of their Phase 1 trial, the potential benefits for tinnitus, why speech intelligibility should be the primary measure of hearing, and when the drug might reach the market.
A drug to quieten your tinnitus, that’s what Thanos Tzounopoulos, PhD, is working on. The drug targets potassium ion channels in the brain. These channels – or so the theory goes – are compromised in tinnitus patients, thus triggering the neural hyperactivity perceived as tinnitus. In spite of trials and tribulations in getting the drug ready for clinical trials, Thanos is optimistic about his chances for success.
While curing tinnitus remains a conundrum, important advances are being made in the field of hearing regeneration, which might also benefit tinnitus sufferers. The Hough Ear Institute talks about two hearing restoration treatments under development.
Sound discomfort and pain can be a hard burden to bear. We talked to Bryan Pollard about hyperacusis, a condition even more poorly understood than tinnitus. Luckily, recent scientific breakthroughs have opened up new treatment avenues.
Do you want to know what stem cells are and how they can treat hearing loss and tinnitus? Learn all about it in this podcast! Featuring professor Marcelo Rivolta, a specialist in hearing regeneration who recently started his own biotech company.
Tinnitus Talk spoke with Dr. Rauschecker, one of the most eminent researchers on tinnitus. We’re excited to launch our podcast series with this highly engaging interview, a must for anyone who wants to understand how tinnitus works in the brain and how we can get to a cure!